Tokyo, Japan

Kohjin Life Sciences Co., Ltd.

USPTO Granted Patents = 8

% Expired Patents = 37.5


Trademarks = 7

Forward Citations = 1

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Kenichi Ason (4 out of 6 patents)

silverMedal Yoshie Yasumatsu (3 out of 4 patents)

bronzeMedal Takaomi Kessoku (2 out of 3 patents)

4.  Atsushi Nakajima (2 out of 6 patents)

5.  Yoshio Sumida (2 out of 2 patents)

6.  Yuichiro Eguchi (2 out of 2 patents)

7.  Yusuke Sauchi (2 out of 2 patents)

8.  Yuki Saito (2 out of 2 patents)

9.  Tomohiro Nakagawa (2 out of 2 patents)

10.  Naoto Kaji (2 out of 2 patents)

11.  Susumu Saito (2 out of 23 patents)

12.  Hiroko Kodera (1 out of 2 patents)

13.  Eiji Nakao (1 out of 2 patents)

14.  Yusuke Fukuda (1 out of 1 patent)

15.  Setsuko Hirakura (1 out of 1 patent)


8 patents:

Company Overview
Kohjin Life Sciences Co., Ltd. is a leading biotechnology company specializing in innovative solutions for health and wellness. With a focus on research and development, Kohjin Life Sciences is dedicated to providing high-quality ingredients and products that promote optimal health and vitality. Our expertise in fermentation technology and nutritional supplements sets us apart in the industry, allowing us to deliver cutting-edge solutions for a healthier world.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#2,151 in Tokyo

#5,049 in Japan

Tokyo, JP
Tokyo, Japan
Forward Citations = 1

21 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kohjin Life Sciences Co., Ltd.. Retrieved from https://idiyas.com/company/kohjin-life-sciences-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…